Gerhard Nehmiz
Impact in
- Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management
- Hepatology top 1%
- Hepatitis C virus research
Papers in
- Hepatology 15
- Hepatitis C virus research 15
- Epidemiology 13
- Hepatitis B Virus Studies 11
- Liver Disease Diagnosis and Treatment 7
- Co-authors
- Lars Wallentin (3 shared papers)Paul Reilly (3 shared papers)Michael D. Ezekowitz (3 shared papers)Joachim Stangier (4 shared papers)Sebastian Haertter (2 shared papers)Thorsten Lehr (1 shared paper)John W. Eikelboom (1 shared paper)Susan Wang (1 shared paper)
- Journals
- British Journal of Clinical Pharmacology (7 papers)Journal of Hepatology (5 papers)Hepatology (5 papers)Antiviral Therapy (3 papers)Gastroenterology (2 papers)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Gerhard Nehmiz
43 papers receiving 2.7k citations
Gerhard Nehmiz's Hit Papers
Peers
Comparison fields: 5 of 95
- Internal Medicine 909
- Hepatology 807
- Cardiology and Cardiovascular Medicine 1.5k
- Epidemiology 803
- Pharmacology 171
Countries citing papers authored by Gerhard Nehmiz
This map shows the geographic impact of Gerhard Nehmiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerhard Nehmiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerhard Nehmiz more than expected).
Fields of papers citing papers by Gerhard Nehmiz
This network shows the impact of papers produced by Gerhard Nehmiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerhard Nehmiz. The network helps show where Gerhard Nehmiz may publish in the future.
Co-authors
The 25 scholars most cited alongside Gerhard Nehmiz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients Hit paper breakdown → | 2013 | 630 |
| 2 | 2007 | 332 | |
| 3 | 2005 | 241 | |
| 4 | 2004 | 233 | |
| 5 | 2004 | 160 | |
| 6 | 2012 | 135 | |
| 7 | 2005 | 121 | |
| 8 | 2013 | 111 | |
| 9 | 2011 | 101 | |
| 10 | 2012 | 98 | |
| 11 | 2013 | 86 | |
| 12 | 1990 | 64 | |
| 13 | 2013 | 60 | |
| 14 | 2009 | 56 | |
| 15 | 1995 | 34 | |
| 16 | 2013 | 33 | |
| 17 | 1996 | 33 | |
| 18 | 2003 | 28 | |
| 19 | 2011 | 28 | |
| 20 | 1996 | 27 |
About Gerhard Nehmiz
Gerhard Nehmiz is a scholar working on Hepatology, Epidemiology, Cardiology and Cardiovascular Medicine, Pharmacology and Pharmacology, having authored 43 papers that have together received 2.8k indexed citations. Recurring topics across this work include Hepatitis C virus research (15 papers), Hepatitis B Virus Studies (11 papers), Atrial Fibrillation Management and Outcomes (9 papers), Liver Disease Diagnosis and Treatment (7 papers), Inflammatory mediators and NSAID effects (7 papers), Pharmacogenetics and Drug Metabolism (5 papers), Venous Thromboembolism Diagnosis and Management (4 papers) and Receptor Mechanisms and Signaling (3 papers). The work is most often cited by research in Internal Medicine (909 citations), Hepatology (807 citations), Cardiology and Cardiovascular Medicine (1.5k citations), Epidemiology (803 citations) and Pharmacology (171 citations). Gerhard Nehmiz has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Lars Wallentin, Paul Reilly, Michael D. Ezekowitz, Joachim Stangier, Sebastian Haertter, Thorsten Lehr, John W. Eikelboom, Susan Wang, Stuart J. Connolly and Salim Yusuf. Their work appears in journals such as British Journal of Clinical Pharmacology, Journal of Hepatology, Hepatology, Antiviral Therapy and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.